What does NEURODEGEN do?

NEURODEGEN is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”, a code that says little about what the company actually does. Private Limited, started on 24 March 2003, 1 establishment.

What is the address of NEURODEGEN?

The registered office of NEURODEGEN is located at Maria-Theresiastraat 32, 3000 Leuven.

Is NEURODEGEN still active?

Yes. According to the CBE (30 September 2026) NEURODEGEN is active, legal situation “Normale toestand”, started on 24 March 2003.

Is NEURODEGEN registered on Peppol?

Yes, NEURODEGEN is registered on the Peppol network with ID 0208:0479829306.

What is the enterprise number of NEURODEGEN?

The enterprise number of NEURODEGEN is BE0479829306.

When was NEURODEGEN founded?

NEURODEGEN was founded on 24 March 2003.

Who are the directors of NEURODEGEN?

According to the 2025 annual accounts, the directors of NEURODEGEN are: Ann Van Damme, Bart De Strooper.

Is NEURODEGEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 March 2003; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did NEURODEGEN make in 2025?

NEURODEGEN posted a profit after taxes of € 265,714 in financial year 2025.

What is the revenue of NEURODEGEN?

As a small company, NEURODEGEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 338,709.

NEURODEGEN (Private Limited) - Leuven - BE0479829306

Dossier NEURODEGEN, printed on 30 September 2026 from databakkes.be/en/0479829306/neurodegen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

NEURODEGEN from Leuven, company number BE0479829306, closed financial year 2025 with a result of € 265,714 after tax. For that financial year NEURODEGEN recorded a gross margin of € 338,709 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 209,346 to € 265,714. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 1.7 million

▲ 17% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 265,714

▲ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 812,780

▲ 173% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 13,743 paid out

5 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 39,759

▲ € 32,330 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 270,343

▼ 27% vs 2024

€ 83,683 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 38

▼ 89% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,416

▼ 15% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 349,111 Gross margin 2022: € 349,111 First fiscal year in the series	€ 415,164 Gross margin 2023: € 415,164 ▲ 19% vs 2022 (€ 349,111) Favourable step	€ 291,780 Gross margin 2024: € 291,780 ▼ 30% vs 2023 (€ 415,164) Unfavourable step	€ 338,709 Gross margin 2025: € 338,709 ▲ 16% vs 2024 (€ 291,780) Favourable step	▲ 16%
Profit after taxes	€ 242,825 Profit after taxes 2022: € 242,825 First fiscal year in the series	€ 286,968 Profit after taxes 2023: € 286,968 ▲ 18% vs 2022 (€ 242,825) Favourable step	€ 209,346 Profit after taxes 2024: € 209,346 ▼ 27% vs 2023 (€ 286,968) Unfavourable step	€ 265,714 Profit after taxes 2025: € 265,714 ▲ 27% vs 2024 (€ 209,346) Favourable step	▲ 27%
Equity	€ 1,099,374 Equity 2022: € 1,099,374 First fiscal year in the series	€ 1,310,092 Equity 2023: € 1,310,092 ▲ 19% vs 2022 (€ 1,099,374) Favourable step	€ 1,442,008 Equity 2024: € 1,442,008 ▲ 10% vs 2023 (€ 1,310,092) Favourable step	€ 1,693,979 Equity 2025: € 1,693,979 ▲ 17% vs 2024 (€ 1,442,008) Favourable step	▲ 17%
Total debts	€ 698,822 Total debts 2022: € 698,822 First fiscal year in the series	€ 655,753 Total debts 2023: € 655,753 ▼ 6% vs 2022 (€ 698,822) Favourable step	€ 656,244 Total debts 2024: € 656,244 Unchanged (€ 655,753) Unfavourable step	€ 583,758 Total debts 2025: € 583,758 ▼ 11% vs 2024 (€ 656,244) Favourable step	▼ 11%
Cash	€ 196,675 Cash 2022: € 196,675 First fiscal year in the series	€ 162,938 Cash 2023: € 162,938 ▼ 17% vs 2022 (€ 196,675) Unfavourable step	€ 298,153 Cash 2024: € 298,153 ▲ 83% vs 2023 (€ 162,938) Favourable step	€ 812,780 Cash 2025: € 812,780 ▲ 173% vs 2024 (€ 298,153) Favourable step	▲ 173%
Retained profit	€ 1,098,874 Retained profit 2022: € 1,098,874 First fiscal year in the series	€ 1,309,592 Retained profit 2023: € 1,309,592 ▲ 19% vs 2022 (€ 1,098,874) Favourable step	€ 1,441,508 Retained profit 2024: € 1,441,508 ▲ 10% vs 2023 (€ 1,309,592) Favourable step	€ 1,693,479 Retained profit 2025: € 1,693,479 ▲ 17% vs 2024 (€ 1,441,508) Favourable step	▲ 17%
Dividend	€ 188,025 Dividend 2022: € 188,025 First fiscal year in the series	€ 76,250 Dividend 2023: € 76,250 ▼ 59% vs 2022 (€ 188,025) Unchanged	€ 77,430 Dividend 2024: € 77,430 ▲ 2% vs 2023 (€ 76,250) Unchanged	€ 13,743 Dividend 2025: € 13,743 ▼ 82% vs 2024 (€ 77,430) Unchanged	▼ 82%
Bank debt	€ 504,549 Bank debt 2022: € 504,549 First fiscal year in the series	€ 442,098 Bank debt 2023: € 442,098 ▼ 12% vs 2022 (€ 504,549) Favourable step	€ 370,779 Bank debt 2024: € 370,779 ▼ 16% vs 2023 (€ 442,098) Favourable step	€ 270,343 Bank debt 2025: € 270,343 ▼ 27% vs 2024 (€ 370,779) Favourable step	▼ 27%
Balance sheet total	€ 1,798,196 Balance sheet total 2022: € 1,798,196 First fiscal year in the series	€ 1,965,845 Balance sheet total 2023: € 1,965,845 ▲ 9% vs 2022 (€ 1,798,196) Unchanged	€ 2,098,252 Balance sheet total 2024: € 2,098,252 ▲ 7% vs 2023 (€ 1,965,845) Unchanged	€ 2,277,736 Balance sheet total 2025: € 2,277,736 ▲ 9% vs 2024 (€ 2,098,252) Unchanged	▲ 9%

Key figures of NEURODEGEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NEURODEGEN?

What happened at NEURODEGEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 265,714 (▲ 27% vs 2024). Source: NBB ↗
2020 Ann Van Damme became a director. NBB
May 12, 2003 New establishment in Leuven. KBO
Mar 24, 2003 Start of the company according to the CBE. KBO
2002 Bart De Strooper became a director. NBB

In short

From € 242,825 profit in 2022 to € 265,714 profit in 2025.

Paid € 470,208 in corporate taxes since 2022.

Best year ever: 2023, with € 286,968 profit.

Paid out € 355,448 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at NEURODEGEN? We notify you, reason included.

Follow NEURODEGEN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ann Van Damme Bart De Strooper

HUISARTSENPRAKTIJK HOEILAART DE DOENDERS

NEURODEGEN

Behind NEURODEGEN are Ann Van Damme and Bart De Strooper. Ann Van Damme is also behind HUISARTSENPRAKTIJK HOEILAART DE DOENDERS.

See the full network in the app

Directors

According to the 2025 annual accounts

Ann Van Damme

Director

Also active at: HUISARTSENPRAKTIJK HOEILAART DE DOENDERS

since 2020

Bart De Strooper

Director

since 2002

Establishments

Establishment units

Physical locations of this company

Registered office

Maria-Theresiastraat 32

3000 Leuven

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0479.829.306

VAT number

BE 0479.829.306

Registered office

Maria-Theresiastraat 32, 3000 Leuven

Names & denominations

NEURODEGEN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

24 March 2003

Peppol

Active · Active since 17 Nov 2025

Activities · NACE

Overige zakelijke dienstverlening, neg

Overige zakelijke dienstverlening, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

NEURODEGEN

Financials

What happened to NEURODEGEN?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions